CVM Cel Sci Corp

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: CVM

Price (delayed)

$1.46

Market cap

$73.15M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.69

Enterprise value

$80.67M

CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival. Therefore, in the Phase 3 study CEL-SCI treated patients ...

Highlights
The company's EPS rose by 19% YoY and by 5% QoQ
CVM's net income is up by 16% year-on-year and by 4.1% since the previous quarter
Cel Sci's quick ratio has plunged by 70% YoY
The equity has plunged by 52% YoY and by 4.3% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.cel-sci.com/
Peers: CASI CRIS BCRX AMGN

Key stats

What are the main financial stats of CVM
Market
Shares outstanding
50.1M
Market cap
$73.15M
Enterprise value
$80.67M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.77
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$30.33M
EBITDA
-$26.34M
Free cash flow
-$23.43M
Per share
EPS
-$0.69
Free cash flow per share
-$0.48
Book value per share
$0.25
Revenue per share
$0
TBVPS
$0.59
Balance sheet
Total assets
$28.71M
Total liabilities
$16.06M
Debt
$13.1M
Equity
$12.65M
Working capital
$1.29M
Liquidity
Debt to equity
1.04
Current ratio
1.26
Quick ratio
1.15
Net debt/EBITDA
-0.29
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-95.7%
Return on equity
-204.3%
Return on invested capital
-92.5%
Return on capital employed
-127.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CVM stock price

How has the Cel Sci stock price performed over time
Intraday
-0.68%
1 week
-2.67%
1 month
-20.22%
1 year
-35.96%
YTD
-46.32%
QTD
-23.56%

Financial performance

How have Cel Sci's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$30.29M
Net income
-$31.05M
Gross margin
N/A
Net margin
N/A
CVM's net income is up by 16% year-on-year and by 4.1% since the previous quarter
Cel Sci's operating income has increased by 13% YoY and by 3.8% from the previous quarter

Growth

What is Cel Sci's growth rate over time

Valuation

What is Cel Sci stock price valuation
P/E
N/A
P/B
5.77
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 19% YoY and by 5% QoQ
The stock's price to book (P/B) is 79% less than its 5-year quarterly average of 27.7 and 16% less than its last 4 quarters average of 6.9
The equity has plunged by 52% YoY and by 4.3% from the previous quarter

Efficiency

How efficient is Cel Sci business performance
CVM's return on equity has dropped by 98% year-on-year and by 18% since the previous quarter
The return on assets has declined by 40% year-on-year and by 8% since the previous quarter

Dividends

What is CVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CVM.

Financial health

How did Cel Sci financials performed over time
The total assets is 79% more than the total liabilities
Cel Sci's current ratio has plunged by 71% YoY
Cel Sci's quick ratio has plunged by 70% YoY
CVM's debt is 3.5% greater than its equity
The company's debt to equity has surged by 86% YoY
The equity has plunged by 52% YoY and by 4.3% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.